Status:
UNKNOWN
Effect of EPAP Device on Emphysema and Lung Bullae
Lead Sponsor:
Qilu Hospital of Shandong University
Conditions:
Emphysema
Bullous Disease Lung
Eligibility:
All Genders
Up to 75 years
Phase:
NA
Brief Summary
The purpose of this study is to evaluate the safety and the effects and of the application of Expiratory Positive Airway Pressure (EPAP) device on Dynamic Hyperinflation and dyspnea in patients with E...
Detailed Description
The trial will last for six months. Patients will be collected clinical and anthropometric data by using questionnaires initially. Patients will have the pulmonary function test and CT scan and conduc...
Eligibility Criteria
Inclusion
- The patient was ≤75 years old
- CT examination revealed emphysema (absolute CT value ≥900) or bullae
- CT do not show other imaging changes of lung diseases, such as mass, exudation and interstitial changes
- No history of lung cancer, pneumonectomy, any history of cystic fibrosis, allergic alveolitis, or pulmonary fibrosis
- Patients volunteer to participate and sign informed consent
Exclusion
- Patients with asthma, bronchiectasis, interstitial lung disease and other basic lung diseases
- Patients with heart failure
- Patients with a history of malignancy
- Patients are reluctant to participate
Key Trial Info
Start Date :
July 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 20 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04742114
Start Date
July 31 2021
End Date
November 20 2022
Last Update
March 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Qilu Hospital of Shandong University
Jinan, Shandong, China, 250012